GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Futura Medical FUM.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.22p

+3.35%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Futura Medical — daily FUM

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Futura Medical on TradingView ↗
Market value
£1.3m
Last close × shares
Volume
40.1m
Shares, 9 Nov 2026

About Futura Medical

Its shares trade on LSE under the ticker FUM.L. It has been listed since 10 July 2006. In the fiscal year to 31 December 2024, it reported revenue of £13.9m and net income of £1.3m. At that date it held total assets of £13.6m and shareholders' equity of £9.0m.

Futura Medical Plc is a pharmaceutical group that develops products for both the prescription and consumer healthcare markets. The company is headquartered in Guildford, Surrey. The company went IPO on 2006-07-10. The firm is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. The company is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin. The company specializes in sexual health and pain relief, and has approximately five products in its development pipeline, which include CSD500, MED2002, TPR100, TIB200 and SPR300. Its CSD500 product incorporates an erectogenic gel (known as Zanifil gel) to help men maintain a firmer erection during intercourse whilst wearing a condom. Its MED2002 is a gel applied directly to the penis for the treatment of male erectile dysfunction (ED). The firm's TPR100 is a gel to provide pain relief. Its SPR300 is a gel, which combines methyl salicylate and menthol with the DermaSys delivery system.

Figures and description from our data supplier, not checked against the company's own report.

More about Futura Medical →

Latest on Futura Medical

Our reporting

We have not reported on Futura Medical yet.

Next results

14 Apr 2027

Due on 14 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Futura Medical's ticker?

Futura Medical trades as FUM.L on LSE, under ISIN GB0033278473.

What was Futura Medical's last closing price?

0.22p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Futura Medical next report results?

Results are expected on 14 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.